PfizerPFE
About: Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Employees: 88,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
51% more first-time investments, than exits
New positions opened: 190 | Existing positions closed: 126
26% more funds holding in top 10
Funds holding in top 10: 31 [Q2] → 39 (+8) [Q3]
3% more repeat investments, than reductions
Existing positions increased: 1,214 | Existing positions reduced: 1,176
1% more funds holding
Funds holding: 2,825 [Q2] → 2,852 (+27) [Q3]
1% less capital invested
Capital invested by funds: $109B [Q2] → $108B (-$896M) [Q3]
2.59% less ownership
Funds ownership: 68.01% [Q2] → 65.42% (-2.59%) [Q3]
38% less call options, than puts
Call options by funds: $2.54B | Put options by funds: $4.07B
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
UBS Colin Bristow 18% 1-year accuracy 3 / 17 met price target | 9%upside $29 | Neutral Maintained | 8 Jan 2025 |
Truist Securities Srikripa Devarakonda 27% 1-year accuracy 9 / 33 met price target | 20%upside $32 | Buy Maintained | 18 Dec 2024 |
Guggenheim Vamil Divan 30% 1-year accuracy 6 / 20 met price target | 24%upside $33 | Buy Maintained | 11 Dec 2024 |
B of A Securities Tim Anderson 67% 1-year accuracy 4 / 6 met price target | 9%upside $29 | Neutral Reinstated | 10 Dec 2024 |
Wolfe Research Alexandria Hammond 33% 1-year accuracy 3 / 9 met price target | 6%downside $25 | Underperform Initiated | 15 Nov 2024 |
Financial journalist opinion
Based on 93 articles about PFE published over the past 30 days
